Beneficial effects of aminohexane diphosphonate in patients with paget's disease of bone resistant to sodium etidronate
- 1 August 1987
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 83 (2), 276-282
- https://doi.org/10.1016/0002-9343(87)90699-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effective short term treatment of Paget's disease with oral etidronate.BMJ, 1986
- Long-term follow-up of therapy with intermittent etidronate disodium in paget's disease of boneAmerican Journal Of Medicine, 1985
- FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASEThe Lancet, 1984
- Long Term Effects of Dichloromethylene Diphosphonate in Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1982
- Long‐term therapy of paget's disease of bone with ehdpArthritis & Rheumatism, 1980
- Use of etidronate (ehdp) in paget's disease of boneArthritis & Rheumatism, 1980
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979